Rani Therapeutics Holdings Inc (RANI)


Stock Price Forecast

March 27, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Rani Therapeutics Holdings Inc chart...

About the Company

Rani Therapeutics is a clinical-stage biotech company that has developed a platform technology to enable oral delivery of biologic drugs.

$11M

Total Revenue

114

Employees

$0M

Market Capitalization

3.66

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $RANI News

Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript

7d ago, source:

Q4 2023 Earnings Call Transcript March 20, 2024 Rani Therapeutics Holdings, Inc. beats earnings expectations. Reported EPS is ...

RANI: 2023 Results

7d ago, source: Zacks Small Cap Research on MSN

RANI READ THE FULL RANI RESEARCH REPORT Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) began 2024 with topline results from ...

Buy Rating for Rani Therapeutics: Promising Clinical Data and Significant Market Potential

3d ago, source:

H.C. Wainwright analyst Mitchell Kapoor has maintained their bullish stance on RANI stock, giving a Buy rating on March 21. Mitchell Kapoor ...

Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

7d ago, source:

Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Announced ...

Rani Therapeutics Holdings, Inc. Class A

9mon ago, source:

View Rani Therapeutics Holdings, Inc. Class A RANI stock quote prices, financial information, real-time forecasts, and company news from CNN.

RANI Stock Earnings: Rani Therapeutics Hldgs Beats EPS for Q4 2023

on MSN ago, source:

RANI stock results show that Rani Therapeutics Hldgs beat analyst estimates for earnings per share the fourth quarter of 2023 ...

Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

12d ago, source: TMCnet

Rani Therapeutics will host a conference call and live webcast at 4:30 p.m. ET / 1:30 p.m. PT on March 20, 2024. Individuals interested in listening to the live conference call may do so by using the ...

Earnings Outlook For Rani Therapeutics Hldgs

9d ago, source: Benzinga.com

Rani Therapeutics Hldgs RANI is set to give its latest quarterly earnings report on Wednesday, 2024-03-20. Here's what ...

Analysts Offer Insights on Healthcare Companies: Aura Biosciences Inc (AURA), Spectral AI (MDAI) and Pyxis Oncology (PYXS)

13h ago, source: Business Insider

Harrison covers the Healthcare sector, focusing on stocks such as MoonLake Immunotherapeutics, Rani Therapeutics Holdings, and Apogee Therapeutics, Inc. The word on The Street in general, suggests a ...

Recap: Rani Therapeutics Hldgs Q4 Earnings

7d ago, source:

Rani Therapeutics Hldgs RANI reported its Q4 earnings results on Wednesday, March 20, 2024 at 04:05 PM. Here's what investors need to know about the announcement. Earnings. Rani T ...

Relmada Therapeutics FY 2023 Earnings Preview

on MSN ago, source:

Relmada Therapeutics is set to release their fiscal year earnings results on March 18th after the market closes.

Target looks to double bonuses this year, Bloomberg News says

on MSN ago, source:

"Based on Target's performance in 2023, including the $2 billion in additional profit growth our team delivered that exceeded ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...